Frequently Asked

Frequently Asked

Homaccords are preparations which contain one or several active substances in respective potency chords. Usually a low potency is combined with a medium potency and a higher potency. The background of this potency combination is the nearly 100 year old therapeutic experience that the simultaneous administration of low, medium, and higher potencies causes a reduction of the initial aggravation. As is known, initial aggravations occur particularly often during the administration of higher potencies given individually.

Homaccords are available both as attenuations for oral administration as well as in ampoule form for subcutaneous injection. This multipotent form – among other applications – is particularly appropriate for treating chronic illnesses.

In the ampoule form of the Homaccords, the individual constituents’ potency-levels are generally two to three stages higher than those found in the drops. These highly- potentised elements exert a subduing effect on any possible initial reactions, hence cases displaying initial aggravation are a rarity.

Through the multiplicity of constituents within Composita preparations, a broad, in-depth therapeutic effect is achieved. The basis for these are the various points of action at which the constituent medications develop their efficacy. The basic principle of the Composita preparations will be explained vicariously with the example of Euphorbium compositum Nasal Spray.

This nasal spray preparation contains as classical homoeopathic botanical constituents Euphorbium, Pulsatilla, and Luffa operculata, further the anorganic-chemical, classical homoeopathic substances Mercurius bijodatus, Argentum nitricum, and Hepar sulfuris, the nosode Sinusitis-Nosode and the suis-organ preparation Mucosa nasalis suis. The constituent ”Euphorbium,“ which lends its name to the preparation, demonstrates clear relations to illnesses of the upper respiratory tract in its drug picture. The organotropically implemented low potency of Euphorbium resinifera is supported by the constituents Pulsatilla, Luffa, Mercurius bijodatus, and Argentum nitricum, which contain in their remedy picture the symptomatology of catarrhal inflammatory processes of the upper respiratory tract according to the Materia Medica Homoeopathica.

An important component of anti-homotoxic therapy is the suis-organ preparation. These are preferably employed for chronic courses of diseases in the cellular phases. Subsequently, they offer an excellent possibility for the reactivation of organ functions, particularly of elderly patients. The preparations are employed according to the simile principle, that is, the respective preparation of the organ to be treated is applied.

Suis- organ preparations contain organic tissues which have been homoeopathically processed, i.e., attenuated and potentized in accordance with Specification 42 of the official German Homoeopathic Pharmacopoeia 1978 (HAB 1) whose primary materials originate from healthy swine. In accordance with their action, the suis-organ preparations can be characterized as organ-specific medications with stimulative properties. The mechanism through which the suis-organ preparations function is based on the organotropic effects of the substances and/or stimulants contained therein.